Scottish scientists plan to 3D print brain tumours in quest for effective drug treatments
A team of scientists from the Heriot-Watt University in Edinburgh intends to 3D print tumour-like constructs to gain better understanding of the biology of...
SPEE3D completes first hot fire trial for AM rocket engine
Additive manufacturing company SPEE3D has successfully completed the first hot fire test for a prototype rocket engine in Darwin as part of its SPACE3D Project.
Alcoa’s Portland Aluminium JV achieves ASI certification for ESG performance
Alcoa’s Portland Aluminium joint venture in Victoria has received its certification from the Aluminium Stewardship Initiative (ASI) for its environmental, social, and governance performance.
Australian Government’s Energy White Paper draws mixed reactions
The Australian Government has released the Energy White Paper which focuses on increasing market competition, energy productivity and investment to give industry and consumers...
ClearVue founder Victor Rosenberg steps down as chairman
ClearVue Technologies Limited has announced that its Non-Executive Chairman and Founder, Victor Rosenberg, has stepped down from his role effective immediately, transitioning to the position of Non-Executive Director as part of his retirement plans.
SPEE3D tapped to bring cold spray additive manufacturing tech to the US Naval Postgraduate...
Victoria-based additive manufacturing company SPEE3D has teamed up with the Consortium for Additive Manufacturing Research and Education (CAMRE) to bolster the adoption of metal-based additive manufacturing to support the US Tri-Service Maritime forces, which includes the Navy, Marine Corps, and Coast Guard.
Grill’d, Sea Forest join forces to launch sustainable beef burger
Australian burger chain Grill’d has announced its collaboration with biotechnology company Sea Forest in an effort to roll out what it claims is a “world-first sustainable,” grass-fed beef burger made from black angus cattle that produce up to two-thirds less methane emissions than regular cattle.
CSL completes acquisition of Novartis flu division
Australian pharmaceutical giant CSL has completed the US $275 million acquisition of Novartis' influenza business.
The transaction will see CSL combine the influenza vaccines division with its...
New research says growing demand for innovative foods in Asia opens up export opportunities
A recent study by independent alternative proteins think tank, Food Frontier, has found that a burgeoning market for alternative proteins in Asia presents an opportunity for Australian and New Zealand manufacturers.
CSL acquires Novartis flu division
CSL is set to become the second largest flu vaccine business in the world with the acquisition of a subsidiary of Swiss pharmaceutical multinational...






















